Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Pomaglumetad Methionil vs SOC in Schizophrenia
NCT00845026Phase 2Completed
- Sponsor
- Denovo Biopharma
- Start
- Mar 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pomaglumetad methionil in schizophrenia, sponsored by Denovo Biopharma. Started Mar 2009; status: completed.
02
Drugs
pomaglumetad methionil
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00845026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845026.